Its one thing to bleat on about the market, but have you...

Its one thing to bleat on about the market, but have you considered those with cancer? Those people are suffering and dying because what ... they are all too stupid to save themselves? After all, according to you IMU has a CURE!

Three people have been dosed with 10mcg of PD1-Vaxx and haven't suffered any unacceptable side effects. The same could be said if they were each given a 10% solution of lime cordial. So on to 50mcg for just three more patients. Even if they and the 100mcg cohort have no unacceptable side effects, we'll still be in the lime cordial category.

At this point IMU will be in a position to trial PD1-Vaxx in order to test for efficacy. All going well (a massive IF as this point), IMU may have advanced treatment for cancer. The results of a Phase II efficacy trial are literally years away.

(I'm aware that some efficacy data is expected to be collected from this Phase 1 trial, but the numbers will be even lower than is the case for HER-Vaxx - ie far too low for the company to seek approval to market the product let alone claim it as a cure for cancer).

We all get that IMU has potential. That potential is currently valued at over $500m (and if you think even that is too low, you should be buying, not highlighting). It doesn't have a cure. It doesn't even have sufficient trial results to obtain approval to market a treatment. Claiming so is insulting to people with cancer.